Myris Therapeutics
  • HOME
  • COMPANY
    • ABOUT
    • OUR TEAM
    • SCIENTIFIC PUBLICATIONS
  • NEWS
  • CONTACT
Select Page

BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member

by Jason Anthony | Sep 16, 2022 | News

Pittsburgh, PA. August 09, 2022 We are excited to announce the appointment of Mark Murcko, Ph.D., as our newest Board Member. Mark brings over three decades of industry experience, having been at the center of many transformational biotech efforts and having...

Recent Posts

  • Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
  • BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership  
  • BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
  • BioHybrid Solutions™ announces the formation of its Holdings Corporation and Subsidiaries
  • BioHybrid Solutions™ Announces Jean Pineault as President and Chief Executive Officer

Recent Comments

    Archives

    • February 2025
    • June 2023
    • September 2022
    • May 2022
    • January 2022
    • December 2019
    • November 2019
    • April 2017
    • November 2016
    • October 2016
    Copyright © Myris Therapeutics